Nomis Bay
1
11M
1
0.11
1
- Areas of investment
Summary
In 2012 was created Nomis Bay, which is appeared as VC.
We can highlight the next thriving fund investment areas, such as Pharmaceutical, Biotechnology. Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Humanigen.
The top amount of exits for fund were in 2017. The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2016. The fund is constantly included in less than 2 investment rounds annually.
The typical case for the fund is to invest in rounds with 3 participants. Despite the Nomis Bay, startups are often financed by Sofinnova Investments, Singapore Bio-Innovations, Mitsubishi UFJ Capital. The meaningful sponsors for the fund in investment in the same round are Cheval Holdings, Black Horse Capital Advisors.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.11
- Investments by industry
- Biotechnology (1)
- Pharmaceutical (1)
- Health Care (1)
- Biopharma (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Avg. valuation at time of investment
- 7M
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.